Pfizer's bladder cancer therapy meets main goal in late-stage study
Pfizer's experimental treatment for a type of bladder cancer significantly improved the time that patients remained free of ...
Cure Today5h
Peter Yarrow Dies of Bladder Cancer, Dick Vitale Cleared for ESPN Return and More
From the death of folk music star Peter Yarrow of Peter, Paul and Mary to good news from broadcasting legend Dick Vitale, ...
Pfizer's Sasanlimab Hits Late-Stage Study Primary Endpoint for Bladder Cancer
Pfizer on Friday said the pivotal Phase 3 study evaluating sasanlimab in combination with standard-of-care Bacillus Calmette-Guerin, or BCG, as induction therapy with or without maintenance in ...
FierceBiotech11h
Pfizer's PD-1 prospect beats age-old incumbent in phase 3 bladder cancer trial
Pfizer’s “golden egg” has hatched. The subcutaneous PD-1 inhibitor improved outcomes when added to the standard of care in ...
BioSpace8h
Pfizer’s Subcutaneous PD-1 Blocker Aces Phase III in Bladder Cancer, Carves Niche Versus Keytruda
If approved, Pfizer’s sasanlimab will distinguish itself from Merck’s blockbuster Keytruda as the first PD-1 inhibitor ...
Pfizer Reveals Encouraging Data From Pivotal Bladder Cancer Trial
Pfizer's Phase 3 CREST trial results highlight the efficacy of sasanlimab combined with BCG in treating high-risk non-muscle invasive bladder cancer.
Targeted Oncology23h
Reviewing the Options for Bladder Cancer in Different Settings
Matthew R. Zibelman, MD, discusses treatment options in muscle-invasive, perioperative, and metastatic bladder cancer.
MEA chief Pinsky under treatment for bladder cancer
Paul G. Pinsky, the longtime state legislator who now heads the Maryland Energy Administration (MEA), told his staff Monday ...
Cure Today4d
Cisplatin-Based Chemo Regimen May Improve Survival in Bladder Cancer
Chemotherapy regimen shows potential to improve survival and reduce need for surgery in patients with muscle-invasive bladder ...